Canada markets closed

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
41.21+0.35 (+0.86%)
At close: 04:00PM EDT
41.90 +0.69 (+1.67%)
After hours: 07:55PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.24B
Enterprise Value 6.41B
Trailing P/E 19.65
Forward P/E 13.50
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)6.68
Price/Book (mrq)62.57
Enterprise Value/Revenue 7.73
Enterprise Value/EBITDA 14.18

Trading Information

Stock Price History

Beta (5Y Monthly) 1.25
52-Week Change 333.62%
S&P500 52-Week Change 325.77%
52 Week High 345.00
52 Week Low 329.85
50-Day Moving Average 339.99
200-Day Moving Average 338.80

Share Statistics

Avg Vol (3 month) 3991.72k
Avg Vol (10 day) 3781.75k
Shares Outstanding 5127.05M
Implied Shares Outstanding 6127.05M
Float 8125.43M
% Held by Insiders 11.12%
% Held by Institutions 1100.00%
Shares Short (Apr 15, 2024) 48.24M
Short Ratio (Apr 15, 2024) 48.73
Short % of Float (Apr 15, 2024) 48.78%
Short % of Shares Outstanding (Apr 15, 2024) 46.48%
Shares Short (prior month Mar 15, 2024) 48.2M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 33.96%
Operating Margin (ttm)45.01%

Management Effectiveness

Return on Assets (ttm)11.89%
Return on Equity (ttm)222.07%

Income Statement

Revenue (ttm)829.25M
Revenue Per Share (ttm)6.29
Quarterly Revenue Growth (yoy)26.70%
Gross Profit (ttm)N/A
EBITDA 416.93M
Net Income Avi to Common (ttm)281.59M
Diluted EPS (ttm)2.10
Quarterly Earnings Growth (yoy)48.00%

Balance Sheet

Total Cash (mrq)336M
Total Cash Per Share (mrq)2.65
Total Debt (mrq)1.53B
Total Debt/Equity (mrq)1,827.33%
Current Ratio (mrq)6.64
Book Value Per Share (mrq)0.66

Cash Flow Statement

Operating Cash Flow (ttm)388.57M
Levered Free Cash Flow (ttm)268.16M